Cellares and TScan collaborate to automate manufacturing of cancer therapies
By
Millie Hoe
1mo agoen
Source
bioprocessintl.comCellares and TScan collaborate to automate manufacturing of cancer therapiesbioprocessintl.comThe partnership will focus on automating T-cell receptor therapies for blood cancers.
You might also wanna read

OHSU logra un gran avance en la ciencia médica con las terapias celulares
Oregon Health & Sciences University·11d ago

DoH and MIT– Koch Institute partner to advance AI-driven Cancer research
Zawya·4d ago

Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an
cell.com·11d ago
UC San Diego AI Model Predicts Cancer Treatment Response from Tumor Genetics
UC San Diego researchers have developed an AI tool called iAtlas that can predict how a tumor will respond to treatment based solely on its
today.ucsd.edu·1mo ago
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
doi.org·12d ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·12d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.